First, let me caution that this is just a mouse study, so it may not hold true in humans
3 The report by Breitzig et al, 4 from data obtained from a commercial claims database, indicates that among privately insured persons with mood disorders, there has been an increase in the prescription of GLP-1 RAs (ie, 1.5%7.2%) during the time period 20182023, with primary care and nurse practitioners rather than psychiatrists increasing prescription volume
[NCBI Bookshelf] ncbi.nlm.nih.gov Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S
Patients commencing GLP-1 therapy often simultaneously make significant lifestyle modificationsincluding dietary changes and increased physical activitywhich may independently contribute to headache symptoms
How long does it take to notice the benefits
It begins with a summary of current biological insights into supersulfides